ENNOGEN INVESTMENTS LTD

13266253
Active Dartford

Manufacture of basic pharmaceutical products

0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsWholesale of pharmaceutical goods
E

ENNOGEN INVESTMENTS LTD

13266253

Manufacture of basic pharmaceutical products

Founded 15 Mar 2021 Active Dartford, England 0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsWholesale of pharmaceutical goods
Accounts Submitted 10 Nov 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Apr 2026 Next due 28 Mar 2027 9 months remaining
Net assets £72M £77K 2024 year on year
Total assets £72M £134K 2024 year on year
Total Liabilities £66K £57K 2024 year on year
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Unit G4 Riverside Way Dartford DA1 5BS England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ENNOGEN INVESTMENTS LTD (13266253), an active life sciences and medical technology company based in Dartford, England. Incorporated 15 Mar 2021. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£45.90k

Increased by £44.49k (+3155%)

Net Assets

£71.58M

Increased by £76.86k (+0%)

Total Liabilities

£65.85k

Increased by £56.84k (+630%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 51,268 Shares £154k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Dec 2025673£94k£140
22 Jan 2024595£60k£100
29 Dec 20221,000£0£0
21 Oct 202149,000£0£0

Officers

Officers

2 active
Status
Ruprai, Gurdev SinghDirectorBritishUnited Arab Emirates6515 Mar 2021Active
Tate, Jason RodneyDirectorEnglishUnited Arab Emirates5014 Jun 2022Active

Shareholders

Shareholders (15)

Ennogen Holdings Ltd
97.6%
51,000
Ennogen Holdings Ltd
0.6%
312

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 29 Dec 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Gurdev Singh Ruprai

Ceased 29 Dec 2022

Ceased

Group Structure

Group Structure

ENNOGEN INVESTMENTS LTD Current Company

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026OfficersChange to director Mr Gurdev Singh Ruprai on 1 Apr 2026
7 Apr 2026CapitalAllotment of shares (GBP 51,012.68) on 30 Dec 2025
7 Apr 2026Confirmation StatementConfirmation statement made on 14 Mar 2026 with updates
10 Nov 2025AccountsAnnual accounts made up to 31 Dec 2024
28 Oct 2025OfficersChange to director Jason Rodney Tate on 15 Oct 2025
10 Apr 2026 Officers

Change to director Mr Gurdev Singh Ruprai on 1 Apr 2026

7 Apr 2026 Capital

Allotment of shares (GBP 51,012.68) on 30 Dec 2025

7 Apr 2026 Confirmation Statement

Confirmation statement made on 14 Mar 2026 with updates

10 Nov 2025 Accounts

Annual accounts made up to 31 Dec 2024

28 Oct 2025 Officers

Change to director Jason Rodney Tate on 15 Oct 2025

Recent Activity

Latest Activity

Change to director Mr Gurdev Singh Ruprai on 1 Apr 2026

2 months ago on 10 Apr 2026

Allotment of shares (GBP 51,012.68) on 30 Dec 2025

2 months ago on 7 Apr 2026

Confirmation statement made on 14 Mar 2026 with updates

2 months ago on 7 Apr 2026

Annual accounts made up to 31 Dec 2024

7 months ago on 10 Nov 2025

Change to director Jason Rodney Tate on 15 Oct 2025

8 months ago on 28 Oct 2025